Jasper Therapeutics, Inc.
JSPR
$5.41
$0.030.56%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 71.64M | 92.50M | 106.82M | 118.48M | 86.89M |
Total Receivables | -- | 250.00K | 250.00K | 250.00K | 250.00K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 1.57M | 1.09M | 1.04M | 1.39M | 1.19M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 2.60M | 968.00K | 575.00K | 192.00K | 615.00K |
Total Current Assets | 75.81M | 94.81M | 108.68M | 120.31M | 88.94M |
|
|||||
Total Current Assets | 75.81M | 94.81M | 108.68M | 120.31M | 88.94M |
Net Property, Plant & Equipment | 2.85M | 3.18M | 3.67M | 3.82M | 4.19M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 1.24M | 1.43M | 1.58M | 1.84M | 1.76M |
Total Assets | 79.90M | 99.41M | 113.93M | 125.96M | 94.89M |
|
|||||
Total Accounts Payable | 4.03M | 3.09M | 2.96M | 2.39M | 4.15M |
Total Accrued Expenses | 9.52M | 7.47M | 5.61M | 5.02M | 6.94M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1.09M | 1.06M | 1.03M | 1.00M | 972.00K |
Total Finance Division Other Current Liabilities | 597.00K | 849.00K | 467.00K | 501.00K | 317.00K |
Total Other Current Liabilities | 597.00K | 849.00K | 467.00K | 501.00K | 317.00K |
Total Current Liabilities | 15.24M | 12.46M | 10.07M | 8.92M | 12.37M |
|
|||||
Total Current Liabilities | 15.24M | 12.46M | 10.07M | 8.92M | 12.37M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 724.00K | 1.01M | 1.29M | 1.55M | 1.81M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 2.26M | 2.26M | 2.26M | 2.26M | 2.26M |
Total Liabilities | 18.23M | 15.73M | 13.62M | 12.73M | 16.45M |
|
|||||
Common Stock & APIC | 302.54M | 300.23M | 298.22M | 296.56M | 248.04M |
Retained Earnings | -240.87M | -216.55M | -197.91M | -183.33M | -169.60M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 61.67M | 83.68M | 100.31M | 113.23M | 78.44M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 61.67M | 83.68M | 100.31M | 113.23M | 78.44M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 61.67M | 83.68M | 100.31M | 113.23M | 78.44M |
|